The Case for Early and Universal Screening for Gestational Diabetes Mellitus: Findings from 9314 Pregnant Women in a Major City in Nigeria.
Gestational diabetes mellitus
Pregnancy
Universal screening
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
11
02
2022
accepted:
27
07
2022
pubmed:
26
8
2022
medline:
26
8
2022
entrez:
25
8
2022
Statut:
ppublish
Résumé
Risk-based screening has been replaced by universal screening as the recommended course of care for gestational diabetes mellitus (GDM). As of 2016, no state in Nigeria had implemented a policy of universal screening for GDM. This research aimed to assess findings from a universal screening programme and its implication for scaling up universal and early screening for GDM. This was a descriptive cross-sectional study conducted in Rivers State Nigeria between February 2017 and January 2020. Multistage sampling was used to recruit 9314 pregnant women from 30 primary, secondary, and tertiary health facilities in the state. An interviewer-administered structured questionnaire was used by trained healthcare workers to collect socio-demographic, obstetric and medical information. All study participants had a plasma glucose test on their first hospital visit and a diagnosis made using the World Health Organization (WHO) criteria. Data obtained was analysed using the IBM Statistical Package for Social Sciences (SPSS) version 23. Most women [5683 (61.0%)] were aged 25-34 (mean 29.60 ± 5.64) years. The prevalence of GDM in this study was 5.2% with a prevalence of GDM in the first, second and third trimesters of 4.9%, 4.2% and 6.7%, respectively. The prevalence of GDM among persons with a family history of diabetes was 13.2% (97 persons) while 4.6% (391 persons) without family history were diagnosed with GDM. Gestational age, family history of diabetes and age group were found to be significant predictors of GDM among the study participants after adjusting for confounding variables. The practice of universal screening was useful in identifying GDM in 1 out of 20 pregnant women in the study sample. Screening at all trimesters was useful in identifying GDM. There is an urgent need to scale up early and universal screening for GDM across sub-Saharan Africa.
Identifiants
pubmed: 36006594
doi: 10.1007/s13300-022-01307-y
pii: 10.1007/s13300-022-01307-y
pmc: PMC9500119
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1769-1778Subventions
Organisme : World Diabetes Foundation
ID : WDF16-1347
Informations de copyright
© 2022. The Author(s).
Références
Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340–6.
doi: 10.2337/dc07-1596
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86.
doi: 10.1056/NEJMoa042973
Bird A, Gilmartin H, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol. 2008;1(3):129.
Moses RG, Cheung NW. Point: universal screening for gestational diabetes mellitus. Diabetes Care. 2009;32(7):1349–51.
doi: 10.2337/dc09-0188
Inturrisi M, Lintner NC, Sorem KA. Diagnosis and treatment of hyperglycemia in pregnancy. Endocrinol Metab Clin N Am. 2011;40(4):703–26.
doi: 10.1016/j.ecl.2011.09.002
Griffin ME, Coffey M, Johnson H, Scanlon P, Foley M, Stronge J, et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med. 2000;17(1):26–32.
doi: 10.1046/j.1464-5491.2000.00214.x
Nielsen KK, de Courten M, Kapur A. The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus–lessons from projects funded by the World Diabetes Foundation. Glob Health Action. 2012. https://doi.org/10.3402/gha.v5i0.17277 .
doi: 10.3402/gha.v5i0.17277
pubmed: 22855644
pmcid: 3409336
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl):S173-211.
doi: 10.1016/S0020-7292(15)30033-3
Bhavadharini B, Uma R, Saravanan P, Mohan V. Screening and diagnosis of gestational diabetes mellitus—relevance to low and middle income countries. Clin Diabetes Endocrinol. 2016;2(1):1–8.
doi: 10.1186/s40842-016-0031-y
Ogu RN, John CO, Maduka O. Screening for gestational diabetes mellitus: findings from a resource limited setting of Nigeria. Br J Med Med Res. 2017;20:1–8.
doi: 10.9734/BJMMR/2017/31966
Ogu RN, Maduka O, Agala V, Alamina F, Adebiyi O, Edewor U, et al. Gestational diabetes mellitus knowledge among women of reproductive age in southern Nigeria: implications for diabetes education. Int Q Community Health Educ. 2020;40(3):177–83.
doi: 10.1177/0272684X19876526
Colagiuri S, Falavigna M, Agarwal MM, Boulvain M, Coetzee E, Hod M, et al. Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Diabetes Res Clin Pract. 2014;103(3):364–72.
doi: 10.1016/j.diabres.2014.02.012
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131:S173-211.
doi: 10.1016/S0020-7292(15)30033-3
Wokoma FS, John CT, Enyindah CE. Gestational diabetes mellitus in a nigerian antenatal population. Trop J Obstet Gynaecol. 2001;18(2):56–60.
doi: 10.1016/S0020-7292(15)30033-3
Azeez TA, Abo-Briggs T, Adeyanju AS. A systematic review and meta-analysis of the prevalence and determinants of gestational diabetes mellitus in Nigeria. Indian J Endocrinol Metab. 2021;25(3):182.
doi: 10.4103/ijem.ijem_301_21
John DH, Awoyesuku PA, MacPepple DA, Kwosah NJ. Prevalence of gestational diabetes mellitus and maternal and fetal outcomes at the Rivers State University Teaching Hospital (RSUTH), Port Harcourt, Nigeria. J Adv Med Med Res. 2019;31(9):1–16.
Abbey M, Kasso T. First trimester fasting blood glucose as a screening tool for diabetes mellitus in a teaching hospital setting in Nigeria. Asian J Med Health. 2018;10(4):1–9.
doi: 10.9734/AJMAH/2018/39385
John C, Alegbeleye J, Otoide A. Foeto-maternal outcome of diabetes in a tertiary health facility in Nigeria. Afr J Diabetes Med. 2015;23(2):13–6.
Koning SH, Hoogenberg K, Lutgers HL, van den Berg PP, Wolffenbuttel BHR. Gestational diabetes mellitus: current knowledge and unmet needs. J Diabetes. 2016;8(6):770–81.
doi: 10.1111/1753-0407.12422
Macaulay S, Dunger DB, Norris SA. Gestational diabetes mellitus in Africa: a systematic review. Schillaci G, editor. PLoS ONE. 2014;9(6):e97871.
doi: 10.1371/journal.pone.0097871
Ogu R, Maduka O. Gestational Diabetes Mellitus Programme in the Niger Delta (WDF16-1347): End Of Project Report. Port Harcourt; 2020.
Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, et al. Gestational diabetes mellitus manifests in all trimesters of pregnancy. Diabetes Res Clin Pract. 2007;77(3):482–4.
doi: 10.1016/j.diabres.2007.01.001
Mohan V, Mahalakshmi MM, Bhavadharini B, Maheswari K, Kalaiyarasi G, Anjana RM, et al. Comparison of screening for gestational diabetes mellitus by oral glucose tolerance tests done in the non-fasting (random) and fasting states. Acta Diabetol. 2014;51(6):1007–13.
doi: 10.1007/s00592-014-0660-5